• Deutsch
    • English
  • Deutsch 
    • Deutsch
    • English
  • Einloggen
Dokumentanzeige 
  •   Startseite
  • Zentren & Graduiertenschulen
  • GGNB - Göttinger Graduiertenzentrum für Neurowissenschaften, Biophysik und molekulare Biowissenschaften
  • Dokumentanzeige
  •   Startseite
  • Zentren & Graduiertenschulen
  • GGNB - Göttinger Graduiertenzentrum für Neurowissenschaften, Biophysik und molekulare Biowissenschaften
  • Dokumentanzeige
JavaScript is disabled for your browser. Some features of this site may not work without it.

The role and regulation of histone H2B monoubiquitination during tumorigenesis

von Theresa Gorsler
Dissertation
Datum der mündl. Prüfung:2013-06-03
Erschienen:2014-05-23
Betreuer:Prof. Dr. Steven Johnsen
Gutachter:Prof. Dr. Steven Johnsen
Gutachter:Prof. Dr. Holger Reichardt
Gutachter:Prof. Dr. Dieter Kube
crossref-logoZum Verlinken/Zitieren: http://dx.doi.org/10.53846/goediss-4504

 

 

Dateien

Name:Dissertation_Theresa Gorsler_3.pdf
Size:3.71Mb
Format:PDF
ViewOpen

Lizenzbestimmungen:


Zusammenfassung

Englisch

Posttranslational histone modifications are recognized as important regulators of gene expression. One of them, the monoubiquitination of lysine 120 of histone H2B (H2Bub1), has diverse functions and is involved in gene transcription as well as in controlling mRNA processing, DNA repair and DNA replication. Notably, H2Bub1 is associated with actively transcribed genes and has been linked to ongoing transcription. The misregulation of H2Bub1-modifying machinery has been observed to be tightly linked with different types of cancer. In the course of this study we clarified aspects of the regulation of the H2B ubiquitinating enzymes and presented data which support the hypothesis that the RNF20/RNF40 complex has a tumor-suppressor function probably through its regulation of H2Bub1. Moreover, we present data that demonstrate a rapid and massive loss of H2Bub1 following various cell stresses. Elucidating the mechanism and signaling pathways which control this process was one major goal of this study. It was demonstrated that H2Bub1 depletion could be rescued through knockdown of various subunits of the deubiquitinating module of the SAGA complex. ChIP-seq analyses obtained in this study demonstrated that H2Bub1 does not cover the entire transcribed region uniformly nor do the average ChIP signal profiles of H2Bub1 correlate with gene expression. However, the deubiquitination and therefore probably the new ubiquitination do correlate with gene activity. Collectively, these studies have uncovered important mechanisms regulating H2Bub1 and may serve as a basis for developing a more solid knowledge of stress-induced H2B deubiquitination and the role of H2B monoubiquitination during tumorigenesis and metastasis. The data provide a potential role of H2Bub1 in epigenetic-based therapy for cancer.
Keywords: tumorigenesis; histone H2B monoubiquitination; transcription
 

Statistik

Hier veröffentlichen

Blättern

Im gesamten BestandFakultäten & ProgrammeErscheinungsdatumAutorBetreuer & GutachterBetreuerGutachterTitelTypIn dieser FakultätErscheinungsdatumAutorBetreuer & GutachterBetreuerGutachterTitelTyp

Hilfe & Info

Publizieren auf eDissPDF erstellenVertragsbedingungenHäufige Fragen

Kontakt | Impressum | Cookie-Einwilligung | Datenschutzerklärung
eDiss - SUB Göttingen (Zentralbibliothek)
Platz der Göttinger Sieben 1
Mo - Fr 10:00 – 12:00 h


Tel.: +49 (0)551 39-27809 (allg. Fragen)
Tel.: +49 (0)551 39-28655 (Fragen zu open access/Parallelpublikationen)
ediss_AT_sub.uni-goettingen.de
[Bitte ersetzen Sie das "_AT_" durch ein "@", wenn Sie unsere E-Mail-Adressen verwenden.]
Niedersächsische Staats- und Universitätsbibliothek | Georg-August Universität
Bereichsbibliothek Medizin (Nur für Promovierende der Medizinischen Fakultät)
Robert-Koch-Str. 40
Mon – Fri 8:00 – 24:00 h
Sat - Sun 8:00 – 22:00 h
Holidays 10:00 – 20:00 h
Tel.: +49 551 39-8395 (allg. Fragen)
Tel.: +49 (0)551 39-28655 (Fragen zu open access/Parallelpublikationen)
bbmed_AT_sub.uni-goettingen.de
[Bitte ersetzen Sie das "_AT_" durch ein "@", wenn Sie unsere E-Mail-Adressen verwenden.]